TrialHematological oncology2026

The Efficacy and Toxicity of CNS Prophylaxis in Diffuse Large B-Cell Lymphoma (CLSG-CNS-01): A Randomized, Multicenter, Prospective Phase 3 Trial.

H Mocikova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.